<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03631108</url>
  </required_header>
  <id_info>
    <org_study_id>2018KY181</org_study_id>
    <nct_id>NCT03631108</nct_id>
  </id_info>
  <brief_title>Feasibility Study and Preliminary Application Study on Iris OCTA</brief_title>
  <official_title>Feasibility Study and Preliminary Application Study on Noninvasive Iris Optical Coherence Tomography Angiography (OCTA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Eye Disease Prevention and Treatment Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Eye Disease Prevention and Treatment Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All participants will underwent imaging using the OCTA system (Zeiss) with the anterior
      segment optical adaptor lens. The main outcomes are iris blood flow density and vascular
      density.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Feasibility study of iris OCTA technology

        2. Establishment of iris OCTA database in normal population and analysis of related
           factors: (1) different sex; (2) different age; (3) different myopic diopter; (4) 24-hour
           diurnal changes from morning to night; (5) before and after mydriasis; (6) different
           blood pressure; (7) different intraocular pressure; (8) different blood glucose; (9)
           before and after exercise. (10) drinking water, tea, coffee and red wine.

        3. Analysis of iris OCTA data related to eye diseases:(1) conjunctivitis; (2) glaucoma; (3)
           childhood myopia; (4) uveitis; (5) diabetic retinopathy; (6) retinal detachment; (7)
           fundus neovascularization.

        4. Influence of commonly used ophthalmic drops on iris OCTA data. Observe the difference of
           iris OCTA test data before and after treatment: (1) conjunctivitis treated with
           levofloxacin antibiotics; (2) glaucoma treated with prostaglandins, adrenalines and
           receptor blockers; (3) childhood myopia treated with atropine drugs (4) uveitis treated
           with hormonal drugs. (5) diabetic retinopathy treated with vasodilator.

        5. Effect on iris OCTA data before and after ophthalmic surgery. (1) cataract,
           phacoemulsification + intraocular lens implantation; (2) glaucoma, iridectomy; (3)
           fundus neovascularization, intraocular injection of anti-VEGF; (4) diabetic retinopathy,
           vitreous surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2018</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Iris Vessel Geometric Characteristics</measure>
    <time_frame>0:00 8:00 14:00 20:00</time_frame>
    <description>Iris vascular density and neovascular density</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Conjunctivitis</condition>
  <condition>Glaucoma</condition>
  <condition>Myopia</condition>
  <condition>Diabetic Retinopathy</condition>
  <condition>Retinal Detachment</condition>
  <condition>Retinal Neovascularization, Unspecified</condition>
  <condition>Uveitis</condition>
  <arm_group>
    <arm_group_label>Normal Population</arm_group_label>
    <description>Normal population with different gender, different age different, different blood pressure, different ocular pressure, etc.
All participants will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with common ophthalmic diseases</arm_group_label>
    <description>(1) conjunctivitis; (2) glaucoma; (3) childhood myopia; (4) uveitis; (5) diabetic retinopathy; (6) retinal detachment; (7) fundus neovascularization.
All patients will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients using eye drops</arm_group_label>
    <description>(1) conjunctivitis patients treated with levofloxacin antibiotics; (2) glaucoma patients treated with prostaglandins, adrenaline or receptor blockers drugs; (3) childhood myopia patients treated with atropine drugs; (4) uveitis patients treated with hormones treatment. (5) diabetic retinopathy patients treated with vasodilator.
All patients will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens before and after eyedrops.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ocular surgery patients</arm_group_label>
    <description>(1) cataract, phacoemulsification + intraocular lens implantation; (2) glaucoma, iridectomy; (3) fundus neovascularization, intraocular injection of anti-VEGF; (4) diabetic retinopathy, vitrectomy.
All patients will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens before and after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>OCTA (ZEISS)</intervention_name>
    <description>All participants will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens.</description>
    <arm_group_label>Ocular surgery patients</arm_group_label>
    <arm_group_label>Patients using eye drops</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Residents of Shanghai and patients from Shanghai Eye Hospital will be selected.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers and ophthalmological patients who can understand and agree to
             cooperate this study will be included.

        Exclusion Criteria:

          -  Patients who can not cooperate with the examination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 12, 2018</study_first_submitted>
  <study_first_submitted_qc>August 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>September 5, 2018</last_update_submitted>
  <last_update_submitted_qc>September 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Iris Vessel</keyword>
  <keyword>OCTA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Retinopathy</mesh_term>
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Retinal Detachment</mesh_term>
    <mesh_term>Retinal Neovascularization</mesh_term>
    <mesh_term>Neovascularization, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

